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Abstract.
The blood-brain barrier (BBB) restricts solute permeability across healthy cerebral endothelial 
cells.  However, during inflammation, permeability is increased and can lead to deleterious 
cerebral edema.  Neutrophils are early cellular participants in acute inflammation, but their effect 
on BBB permeability is unclear.  To study this, neutrophils were applied in a resting and 
activated state to in vitro and in vivo models of the BBB.  In vitro, human neutrophils (5 X 
106/ml) were activated with tumor necrosis factor (100U/ml) and leukotriene B4 (10-7mol/l). 
Untreated neutrophils reduced permeability across the human brain endothelial cell line hCMEC/
D3.  Activated neutrophils returned permeability to baseline, an effect blocked by the reactive 
oxygen scavengers superoxide dismutase (10U/ml) and catalase (1000U/ml).  In vivo, human 
neutrophils (2.5 X 105 in 4μl) were injected into the striatum of anesthetized juvenile Wistar rats, 
and BBB permeability measured 30 minutes later.  This was compared to control injections (4μl) 
of vehicle (0.9% saline) and arachidonic acid (10-3mol/l).  The injection generated a small 
hematoma around the injection tract (<3μl).  Untreated neutrophils induced significantly lower 
permeability in their vicinity than activated neutrophils, with a trend to lowered permeability 
compared to the vehicle control.  Neither untreated nor activated neutrophils induced 
permeability increases, while arachidonic acid increased permeability as a positive control.  This 
study further delineates the effect of neutrophils on the BBB, and demonstrates that resting 
neutrophils induce acute reductions in permeability while activated neutrophils have a neutral 
effect.  The in vivo model reiterates some aspects of acute intracerebral hemorrhage. 
Section: Cellular and molecular biology of nervous systems.
Keywords: blood-brain barrier, neutrophil, inflammation, hemorrhage.
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1. Introduction.
The blood-brain barrier (BBB) is a term used to describe a low permeability to hydrophilic 
solutes across the endothelial cells that line cerebral microvessels (Reese & Karnovsky, 1967). 
In health, the BBB preserves the ionic composition of the brain interstitium, necessary for 
normal neuronal function.  However, during inflammation, BBB permeability is increased.  One 
consequence of this is the extravasation of plasma proteins into the brain, with net retention of 
brain water (Simard et al, 2007).  The subsequent tissue edema is clinically deleterious, 
contributing to the morbidity and mortality in acute inflammatory diseases of the central nervous 
system (CNS) such as hemorrhagic and ischemic stroke, meningitis and head injury.  This 
vasogenic form of cerebral edema is difficult to treat, and its pathogenesis is incompletely 
understood.
Neutrophils are white blood cells that act as early cellular participants in acute cerebral 
inflammation.  The inflammatory state causes activation of cerebral endothelial cells, leading to 
the adhesion and transmigration of neutrophils through the endothelial barrier into the tissues. 
Neutrophils may also extravasate directly into the brain following an acute hemorrhage without 
first undergoing transmigration.  Neutrophils undergo a process of activation in response to 
inflammatory factors, which includes activation of NADPH oxidase and generation of reactive 
oxygen species (ROS) such as superoxide, which have been implicated as mediators of BBB 
permeability increases.  At any of these stages (neutrophil-endothelial interactions, 
transmigration, direct tissue effects and activation) neutrophils may therefore impact on the BBB 
and potentially contribute to vasogenic edema.  
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Where neutrophils have been studied in animal models of CNS disease, results have been 
conflicting.  For instance, the time over which neutrophils infiltrate an ischemic stroke 
(beginning at 6h in experimental studies in the rat (Barone et al, 1995) and 15h in humans 
(Lindsberg et al, 1996) and persisting for days) mirrors edema development, suggesting that 
neutrophils could be causal factors (Lindsberg et al, 1996; Zhang et al, 1994, Del Zoppo et al, 
2001).  However studies in animal disease models have been contradictory, with some 
correlating neutrophils to indicators of brain edema (Del Maschio et al, 1999; Matsuo et al, 1994; 
Wispelwey et al, 1988; Yamasaki et al, 1995).  Others show no relationship (Adelson et al, 1998; 
Hartl et al, 1997; Tauber et al, 1988; Whalen et al, 1999) while others suggest that neutrophils 
reduce BBB disruption (Ahmed et al, 2000; Lo et al, 1998; Schurer et al, 1990).
The contradictory findings of these studies may perhaps be explained by the numerous variables 
that operate between models.  It is not clear whether neutrophils are activated, what mediators 
they secrete or at what anatomical level they operate, for instance by occluding microvessels 
with subsequent reperfusion injury or acting from within the tissues on a variety of cellular 
components (neurons, glia etc).  Another approach is to apply neutrophils directly to models of 
the BBB.  Previous work carried out by our group determined that untreated neutrophils 
(untreated in the sense that inflammatory factors were not applied to induce neutrophil 
activation) reduce permeability across an in vitro model of the BBB made up of cerebral 
endothelial cells.  When neutrophils were induced to migrate through the endothelial barrier they 
tended to return the permeability to baseline without inducing net permeability increases (Inglis 
et al, 2004).  This may function to preserve the integrity of the BBB during neutrophil 
diapedesis.  In vivo studies have increased neutrophil infiltration through stereotactic injections 
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of cytokines (interleukin 1-β) or chemokines (cytokine induced neutrophil chemoattractant-1) 
into the previously normal brain.  Particularly in juvenile rats, these agents induced a major 
neutrophil dependent increase in BBB permeability (Anthony et al, 1997; 1998).  However it is 
not clear if these effects would differ in an inflammatory setting.  Also, neutrophils are admixed 
with the other components of blood and so enter the brain directly in the early stages of acute 
intracerebral hemorrhage, where they may have different effects.  
The approach we have adopted in this study is to apply neutrophils directly to a simplified model 
of cerebral endothelial cells in vitro, and to inject them directly into the CNS parenchyma in 
vivo, with determinations of BBB permeability.  We principally wished to contrast the effects of 
untreated versus activated neutrophils on BBB permeability, measured 30min after application. 
It was not our intention to extensively model any particular CNS disease, however the in vivo 
model can be taken to mimic the early stages of neutrophil extravasation into an acute 
intracerebral hemorrhage (hemorrhagic stroke).   
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2. Results.
Permeability across the human brain endothelial cell line hCMEC/D3.
hCMEC/D3 are a cell line derived by immortalizing human primary brain endothelial cells with 
telomerase and SV40 large T antigen (Weksler et al, 2005).  In order to compare their responses 
to other cell culture models of the BBB, hCMEC/D3 cells were treated with agents reported to 
reduce or increase permeability (Rubin et al, 1991; Easton & Fraser, 1998).  Baseline 
permeability across untreated monolayers, calculated from the clearance of 4kd FITC dextran, 
was 7.99 ± 0.73 X 10-4cm/min (mean ± standard error of the mean).  In one set of experiments, 
cells were pre-treated for 24h with a combination of dibutyryl cyclic AMP (dbcAMP, 2.5 X 10-
4mol/l) and rolipram, a selective phosphodiesterase 4 antagonist that inhibits intracellular cAMP 
degradation (1.75 X 10-5mol/l).  This treatment significantly reduced permeability below baseline 
to 4.53 ± 0.31 X 10-4cm/min.  In other experiments, cells were treated acutely with arachidonic 
acid (0.5 X 10-3mol/l) which significantly increased permeability to 18.99 ± 3.81 X 10-4cm/min 
(fig 1).
Figure 1 near here
The effect of neutrophil activation on permeability across hCMEC/D3.
Neutrophil activation involves the production of reactive oxygen species (ROS) in response to 
external stimuli.  Superoxide is generated by neutrophil NADPH oxidase, an enzyme that 
requires preassembly at the plasma membrane prior to full activation.  To activate neutrophils, 
they were treated with tumor necrosis factor (TNF) and leukotriene B4 (LtB4).  TNF has been 
shown to induce preassembly of NADPH oxidase, which enhances superoxide production by 
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neutrophils in response to LtB4 (Palmblad et al, 1984; Berkow et al, 1987; Sheppard et al, 2005). 
To confirm activation, an in vitro assay was carried out.  ROS production was measured by 
loading neutrophils with carboxy-2’,7’-dichlorodihydrofluorescein diacetate (carboxy-
H2DCFDA).  The change in carboxy-H2DCFDA fluorescence over a 135 minute observation 
period is shown in fig 2A.  The vehicle control (phosphate buffered saline, PBS) did not alter 
fluorescence.  Untreated neutrophils generated an increase in fluorescence, significantly greater 
than vehicle alone (P<0.001).  Compared to untreated neutrophils, fluorescence did not increase 
when neutrophils were pre-treated for 1h with TNF (100 /ml).  However treatment with LtB4 (1 
X 10-7 mol/l) alone or following TNF pre-treatment significantly increased fluorescence, both to 
comparable levels.  Treatment with phorbyl 12-myristate, 13-acetate (PMA, 4 X 10-8mol/l) 
induced an increase in fluorescence that was significantly greater than LtB4 (P<0.001), which 
was blocked in combination with the NADPH oxidase inhibitor diphenylene iodinium chloride 
(DPI, 8 X 10-6 mol/l).
Neutrophils were then applied to hCMEC/D3 to determine their effects on permeability (fig 2B). 
Permeability is expressed as a percentage of the mean permeability across untreated monolayers 
measured concurrently (% of baseline).  Baseline permeability across the untreated inserts used 
in these experiments was 6.02 ± 0.44 X 10-4cm/min (n=18).  Untreated neutrophils were applied 
above the monolayers at a density of 5 X 106/ml, which reflects neutrophil counts in whole blood 
(4-11 X 106/ml).  We previously observed that it took 30min to see maximum changes in 
permeability (Inglis et al, 2004) so neutrophils were left for 30min before permeability was 
measured.  Untreated neutrophils reduced permeability to 47.67 ± 2.57 % of baseline (n=7), a 
significant reduction.  However, when neutrophils were exposed to a gradient of LtB4 (10-7mol/l) 
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applied below the cells, permeability increased to 86.78 ± 10.60 % of baseline (n=9), 
significantly greater than untreated neutrophils and not different from baseline.  To activate 
neutrophils, they were pre-treated with 100U/ml TNF for 1h.  TNF was then removed by 
washing, and neutrophils resuspended in fresh medium before application, to avoid additional 
effects of TNF on permeability.  LtB4 (1 X 10-7mol/l) was then applied first above and then 
below the monolayers, to avoid a gradient.  The resulting permeability was both significantly 
greater than untreated neutrophils, and not significantly different from baseline (81.42 ± 3.03% 
of baseline, n=12).  However, this effect was blocked by the combined ROS scavengers 
superoxide dismutase (10U/ml) and catalase (1000U/ml), in whose presence permeability was 
significantly reduced below baseline, and not significantly different from untreated neutrophils 
(56.97 ± 2.95 % of baseline, n=12).  To determine if LtB4 increases permeability independent of 
neutrophils, permeability was measured following application of LtB4 alone.  This did not result 
in significant differences compared to baseline (97.85 ± 10.56 % of baseline, n=15).
 
Figure 2 near here
In vivo changes in permeability around a striatal injections of neutrophils.
Permeability was measured around striatal injections in anesthetized juvenile Wistar rats.  The 
negative control contained vehicle alone (0.9% saline).  The three other injectates contained 
untreated neutrophils (2.5 X 105 per injection), activated neutrophils and arachidonic acid (1 X 
10-3mol/l).  Activated neutrophils were pre-treated with Tumor necrosis factor (TNF) prior to 
injection (100U/ml, 1h).  TNF was removed by washing before neutrophils were injected. 
Following injection, Leukotriene (Lt)B4 was injected intravenously (variable doses in 200µl 
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saline) to give an estimated circulating concentration of 10-7mol/l, based on dilution in a 
circulating volume estimated at 7% rat body weight.  This circulated for 15min prior to 
intravascular infusion of HRP used as the in vivo permeability tracer.  These factors were chosen 
to mimic the activation conditions used in vitro.  The injection procedure induced a small 
hematoma in the injection tract, whose volume was measured by image analysis.  In the saline 
injected group the volume was 1.09 ± 0.23μl (mean± sem, range: 0.25-2.67μl, n=10 rats).  The 
volume around untreated neutrophils was 0.67 ± 0.09μl (0.32-1.48μl, n=15 rats) while that 
around activated neutrophils was 0.89 ± 0.12μl (0.45-1.48μl, n=9 rats).  There were no 
statistically significant differences in hematoma volume between the groups.  Examples of the 
appearance of the injection site and of how permeability maps were constructed around it are 
shown in figure 3.  Fig 3A shows activated neutrophils, while fig 3B shows an area adjacent to 
the injection site for arachidonic acid.  Upper and lower panels show the 30µm sections (H&E) 
immediately anterior and posterior to the 120µm section that was processed to generate a 
permeability map (middle panel), in which pixels have been pseudocolored to indicate regional 
differences in permeability-surface area (PS) product.  In fig 3A, the permeability map shows a 
linear region of increased permeability in the vicinity of the hematoma.  Fig 3B shows dilated 
microvessels in the vicinity of arachidonic acid (H&E sections), while there are multiple regions 
of increased permeability discernable in the permeability map.  
Figure 3 near here
Average PS was calculated in contiguous regions of interest in the vicinity of the injection site. 
For example, one region would be analyzed in fig 3A, with multiple regions analyzed in fig 3B. 
10
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
PS values were then averaged for all the regions of interest in each rat, to obtain a single value of 
PS per rat.  Multiple values, each one derived from a separate rat, were averaged to obtain PS 
values for each treatment group, shown in figure 4.  PS increased around the saline vehicle to 
112.37 ± 39.06 X 10-6ml/s/g.  In comparison, the PS reduced around untreated neutrophils (to 
59.03 ± 26.97 X 10-6ml/s/g) however the reduction was not statistically significant.  The PS 
around activated neutrophils (89.90 ± 23.27 X 10-6ml/s/g) was also not significantly different 
from saline, and there was no significant difference between untreated and activated neutrophils. 
The PS around arachidonic acid increased to 499.28 ± 94.79 X 10-6ml/s/g, which was 
significantly increased over all other groups (P<0.05 compared to activated neutrophils and 
saline, P<0.001 compared to untreated neutrophils).  
Figure 4 near here
The data is also expressed as PS values from all regions of interest in the permeability maps, 
pooling the data from all of the rats.  This is shown as histograms for each treatment group in 
figure 5.  Values around untreated neutrophils were significantly reduced compared to activated 
neutrophils (X2=13.98, P<0.01).  Both activated and untreated neutrophils were not significantly 
different from the saline group.  However, arachidonic acid was significantly greater than saline 
(X2=107.04, P<0.001).
Figure 5 near here
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3. Discussion.
Summary of findings.
BBB permeability was measured 30 minutes after application of neutrophils (untreated or 
activated) to in vitro and in vivo models.  The in vitro model employed the human brain 
endothelial cell line hCMEC/D3.  When human neutrophils (5 X 106/ml) were applied to the 
monolayers, untreated cells induced significant reductions in permeability.  Subsequent 
activation with TNF (100U/ml) and LtB4 (10-7mol/l) increased permeability relative to the 
untreated neutrophils, but did not increase permeability over baseline.  This increase was 
mediated by reactive oxygen species (ROS), as it could be blocked with the combined ROS 
scavengers superoxide dismutase (10U/ml) and catalase (1000U/ml).  The in vivo model 
employed direct striatal injections of neutrophils (2.5 X 105 in 4μl) using a 26 gauge metal 
needle that also generated acute hemorrhage in the needle tract (final volume under 3μl). 
Neutrophils were either untreated or activated by TNF pretreatment and administration of 
intravenous LtB4 at the doses used in vitro.  Permeability was also assessed at 30min in the 
animal model.  The injection procedure and associated hemorrhage generated an increase in BBB 
permeability around the vehicle control.  The introduction of untreated neutrophils into the 
injection field reduced permeability compared to activated neutrophils (fig 5) with a trend to a 
reduction compared to vehicle (fig 4).  However, permeability around activated neutrophils was 
not different from the vehicle control.  The data show that untreated neutrophils reduce BBB 
permeability while activated neutrophils have neutral effects, whether they are applied in vitro or 
in vivo.
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In vitro model of the BBB.
hCMEC/D3 cells are derived by immortalization of human brain primary endothelial cells using 
SV40 large T antigen and telomerase (Weksler et al, 2005).  The advantage of using hCMEC/D3 
cells is that they model the human BBB, express a number of properties of the in situ BBB, 
maintain those properties reliably over several passage numbers, and avoid the inherent 
variability as well as the difficulty of sourcing that apply to human primaries.  The cells mimic 
the changes in permeability across the BBB that occur in situ in response to inflammatory 
mediators.  We show that arachidonic acid applied at the same concentration used in vivo, 
induced a significant increase in permeability as a positive control, while treatment of 
hCMEC/D3 to enhance levels of intracellular cyclic AMP reduced permeability as a negative 
control (fig 1).  This data provides further validation for using hCMEC/D3 to model changes in 
BBB permeability.  Dextran clearance was chosen to measure permeability, based on the initial 
description of hCMEC/D3.  This study (Weksler et al, 2005) showed that use of dextran 
generated permeability values that were comparable to primary bovine brain endothelial cultures. 
Like Weksler et al (2005), we found that transendothelial electrical resistance was too low in the 
monolayers (baseline under 30Ω.cm2) to permit this to be used to measure the permeability.  This 
appears to relate to the static conditions of the assay rather than a deficiency in the cell line as 
such, since TEER can be increased when cells are exposed to shear stress (Cucullo et al, 2008) or 
grown in serum free medium supplemented with hydrocortisone (Forster et al, 2008).  While 
fluorescent dextrans are useful for the in vitro model, we used a different marker for the in vivo 
study.  The use of HRP was partly dictated by the method described by Gauden et al (2007).  We 
were also concerned that fluorescent dyes in brain slices can prove unreliable, since in tissue 
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stored for several days the fluorescent label could dissociate from the tracer molecule, and during 
processing its intensity could reduce through photobleaching.  
There was similarity between the in vitro and in vivo findings.  When untreated neutrophils were 
applied to the hCMEC/D3 monolayers, they induced a significant reduction in permeability 
30min after application.  We did not explore the mechanism, but our previous work (Inglis et al, 
2004) showed that neutrophils reduce permeability through adenosine and ROS.  Treatment with 
TNF and LtB4 resulted in generation of ROS, assessed in an independent assay (fig 2A).  The 
assay has limitations, because the dye used is intracellular and so may not detect most of the 
superoxide released extracellularly by the activated neutrophils.  This may explain why TNF 
treatment appeared not to potentiate ROS production in response to LtB4.  However, these 
activation conditions negated the permeability reduction seen with the untreated neutrophils, but 
without raising permeability above baseline.  This small increase in permeability back to baseline 
was blocked with the ROS scavengers catalase and superoxide dismutase.  It is of interest that 
ROS reduce permeability when untreated neutrophils are applied to brain endothelial monolayers 
(Inglis et al, 2004), but mediate small increases in permeability when neutrophils are activated. 
Other in vitro studies have demonstrated that neutrophils increase permeability during migration 
across cultured primary brain endothelium, both bovine (Inglis et al., 2004) and human (Wong et 
al, 2007).  However, our previous work (Inglis et al, 2004) suggests that neutrophils also reduce 
permeability in the period preceding migration, so that little net increase occurs.  This was 
reproduced in this study when untreated neutrophils were applied to human hCMEC/D3 
monolayers followed by a chemotactic gradient of LtB4 that would be expected to induce 
transmigration (fig 2B).  
14
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
In vivo model of the BBB.
The use of direct injections of leucocytes into the brain is not an entirely novel approach, as it 
has been employed in studies of acute intracerebral hemorrhage (Xue and Del Bigio, 2000).  We 
chose to assess the impact of injected neutrophils after 30min to match our observations with 
those of the in vitro model (fig 2).  Also, in order to optimize the effect of neutrophil activation, 
LtB4 was injected intravenously after the neutrophils were injected.  As LtB4 is lipid soluble, we 
expected it to gain ready access to the brain.  In previous work on single pial microvessels in the 
same age and species of rat, we had observed that 10-7mol/l LtB4 does not itself alter 
permeability (A Easton, unpublished observation).  By injecting neutrophils directly into the 
brain we were mimicking the effect of extravasated neutrophils, admixed with the other blood 
components that enter the tissue in the earliest stages of acute intracerebral hemorrhage.  This 
makes the method relevant to a pathophysiological situation in which inflammation plays a part, 
however it was not our intention to examine this exhaustively.  In acute intracerebral 
hemorrhage, injury to the BBB develops over a period of several hours, peaking at 48h in the rat. 
Also, this is associated with endogenous neutrophils that take several hours to diapedese into the 
injured brain, and cerebral edema develops around larger hematomas than that generated in this 
study, of the order of 100μl in experimental models of acute intracerebral hemorrhage in the rat 
(Jenkins et al, 1989; Kitaoka et al, 2002).  Therefore we have not modeled several aspects of 
acute intracerebral hemorrhage including the role of neutrophils at later times after injury, and 
their effect on larger hematomas which are more clinically relevant in terms of edema formation. 
However, this study does show that extravasated neutrophils can reduce early injury to the BBB 
around a small hematoma.  A recent paper (Keep et al, 2005) discusses the role of neutrophils (as 
well as other factors) in the pathogenesis of acute intracerebral hemorrhage, and suggests that 
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they might have beneficial effects in small hematomas (under 50μl in the rat) but have 
detrimental effects in larger hematomas.  This is a concept supported by our data.  It is possible 
that neutrophils administered to a larger hematoma, or at later times in a model of acute 
intracerebral hemorrhage would not have reduced the permeability.
In the rat, significant injury is induced when 100μl of whole blood is injected into the striatum 
(Kitaoka et al, 2002).  The true relative blood volume of leucocytes in this volume of blood is 
about 4μl.  The density of neutrophils in the vicinity of intracortical blood injection was reported 
as ca. 200-400/mm2 (Xue & Del Bigio, 2000).  If it is assumed that each standard 5μm tissue 
section contains the same number of neutrophils, then a volume of 1μl would contain 40,000-
80,000 neutrophils, so that 4μl would contain 160,000-320,000 neutrophils.  To mimic these 
conditions, we therefore chose to inject 250,000 neutrophils in 4μl.  The in vivo procedure 
resulted in a significant reduction in permeability when untreated neutrophils were compared 
with activated cells (fig 5), as well as a trend to reduced permeability when the per rat data was 
examined (fig 4).  Perhaps of equal significance is the observation that none of the groups of 
neutrophils (untreated or activated) generated significant increases in permeability over that 
generated around the hematoma itself, although increases were possible as shown for the positive 
control (arachidonic acid, figs 3-5).  As we have suggested, this data suggests a possible 
beneficial role for extravasated neutrophils in the mitigation of permeability increases during the 
acute stages of hematoma formation.  However this study does not determine if these effects only 
apply to small hematomas, or if the effect is restricted to the milieu associated with the earliest 
stages of injury.  Perhaps those neutrophils that diapedese into the brain around the hematoma 
site would exert different effects that are either dependent on hematoma size or on direct 
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neutrophil-endothelial interactions.  The latter point is not addressed by the in vivo portion of 
this study.  However, untreated neutrophils do reduce permeability as they come into contact 
with the endothelium according to our in vitro data (fig 2B). 
The similarity of results in the in vitro system helps to validate the use of injecting human 
neutrophils into the rat model.  It is likely that soluble factors such as reactive oxygen species are 
involved in the regulation of permeability by neutrophils, and these soluble factors would operate 
across different species.  From a practical perspective, we chose to inject human neutrophils into 
the rat because of technical difficulties in extracting sufficient numbers of neutrophils from rat 
blood.  Methods used by other investigators involve increasing rat neutrophils by using 
inflammatory stimuli, or by direct extraction from bone marrow, but both methods would make it 
difficult to extract relatively quiescent neutrophils.  This would have interfered with our aim to 
compare responses between untreated and activated neutrophils.  The histological sections were 
obtained to confirm that neutrophils were present in the sections used to generate permeability 
maps.  However the thickness of the sections (30μm) as well as the admixture of neutrophils and 
red blood cells (see fig 3) prevented the sections being used to measure the distance between 
neutrophils and surrounding microvessels.
The in vivo data can be used to estimate an equivalent permeability coefficient for Horseradish 
peroxidase (HRP), and by extension, to the smaller molecule Lucifer yellow.  This is of interest 
because Lucifer yellow was used in other studies by our group to measure permeability changes 
across inflamed pial microvessels in the same age and species of rat (Easton & Fraser, 1994).  To 
estimate HRP permeability, the data was divided by 142cm2/g, the surface area of microvessels 
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measured in rat striatum (Schlageter et al, 1999).  If HRP and Lucifer yellow diffuse freely 
through the same permeability pore, the values may be multiplied by the ratio of the free 
diffusion coefficients for the two molecules (9.81) to obtain an estimate of Lucifer Yellow 
permeability (PestLY).  While this is an assumption, it can be based on the observation that values 
for Lucifer yellow and albumin permeability (albumin has a similar size to HRP) in inflamed 
cerebral microvessels do approximate to this ratio (Easton & Fraser, 1994).  For the per rat data 
shown in fig 2 PestLY is 7.77 ± 2.70 X 10-6cm/s for saline, 4.08 ± 1.87 X 10-6cm/s for untreated 
neutrophils, 6.22 ± 1.61 X 10-6 cm/s around activated neutrophils and 34.53 ± 6.55 X 10-6cm/s 
for arachidonic acid.  The latter can be compared to our work on the effect of arachidonic acid in 
single pial microvessels.  Mean PLY induced by 10-3mol/l arachidonic acid in pial microvessels 
was 12.61 ± 3.44 X 10-6cm/s (Easton & Fraser, 1998), which is the same order of magnitude as 
our estimate in this study.  This value is also within the range of actual PLY observed in the single 
vessels (0.65-63.51 X 10-6cm/s).  This supports the notion (proposed by Gauden et al (2007)) that 
responses are comparable between smaller pial microvessels (diameter under 30µm) and vessels 
in the parenchyma.  This is an important observation, because it is often argued that responses in 
pial microvessels do not reflect changes seen in the brain as a whole.  This analysis also validates 
the technique used to measure permeability in this study.
Conclusion.
In a wider context, the role of neutrophils in the pathogenesis of BBB disruption and vasogenic 
cerebral edema is controversial.  This study shows that relatively quiescent neutrophils can 
reduce BBB permeability, and suggests that neutrophil activation alone is not sufficient to induce 
net disruption of the BBB.  The in vivo model has limited application to acute intracerebral 
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hemorrhage and the role of extravasated neutrophils early in this disease, but the significance of 
our findings in the broad context of cerebral disease remains to be determined. 
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4. Experimental procedures.
Materials.
Unless otherwise stated, all reagents were obtained from Sigma-Aldrich (Missisauga, ON). 
Arachidonic acid and leukotriene B4 were dissolved as stock solutions in 100% ethanol. 
Solutions were freshly prepared by removing stock solution and evaporating the ethanol with a 
stream of 100% N2 gas, immediately dissolving the residue in 0.1mol/l Na2HCO3.  This was then 
diluted in saline (0.9% NaCl) before application to give a maximum final Na2HCO3 
concentration of 1 X 10-3mol/l.
Cell cultures.
The human brain endothelial cell line hCMED/D3 was generated by three of the authors (Drs 
Weksler, Couraud and Romero; Weksler et al, 2005) and kindly provided by Dr Weksler to Dr 
Easton’s laboratory, where these studies were performed.  The cells were recovered from liquid 
nitrogen at the 4th passage after subcultivation, and initially plated onto uncoated plastic in 
complete EGM-2MV medium (Microvascular Endothelial Cell Medium-2, Cambrex, 
Walkersville, MD).  Complete medium consisted of EGM-2MV medium with added 2.5% fetal 
bovine serum and a supplement containing hydrocortisone and growth factors.  The medium was 
replaced every 3-5 days, and cells reached confluency after 10-15 days.  Cells were passaged 
using trypsin-EDTA (1X) for subsequent use in permeability experiments.
Neutrophil isolation, neutrophil activation assay.
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Neutrophils were isolated from human donor venous blood, as previously described (Inglis et al, 
2004), and used within 6h of isolation.  5 X 105 neutrophils were added to wells of a 96 well 
plate in 100µl aliquots, and the assay initiated by the addition of the reactive oxygen species 
(ROS) sensitive fluorescent dye carboxy-2’,7’-dichlorodihydrofluorescein diacetate (10-5mol/l; 
Invitrogen, Burlington, ON).  Neutrophils were then combined with activating factors as detailed 
in the Results, and the final volume in the wells was brought up to 150µl with PBS. 
Fluorescence was recorded on a microplate reader (Fluoroskan Ascent FL, Thermo Electron, 
Vantaa, Finland) at 485nm (excitation) and 527 nm (emission) every 15min for 135min.
In vitro permeability measurements.
hCMEC/D3 were seeded onto collagen inserts (0.4μm pore size, Transwell, Corning-Costar, 
Fisher Scientific, Whitby, ON) in complete EGM-2MV medium at 5 X 105 cells/cm2.  Cells were 
grown to confluency over 10 days before use.  Permeability was assessed from the clearance of 
fluorescein isothiocyanate (FITC) labeled dextran (4kd molecular weight).  The inserts were 
placed in wells of 12 well plates.  To measure permeability, FITC-dextran (5mg/ml) was added 
to the inserts, which were then transferred every 5min over 30min to a series of collecting wells 
containing 1.5ml of fresh medium.  100µl samples from the collecting wells were placed in a 96 
well plate, and the dextran fluorescence determined on the microplate reader at 485nm 
(excitation) and 538nm (emission).  Fluorescence was converted to concentration using a 
standard curve.  The volume cleared was calculated from the ratio of dextran concentration in 
each sample to the applied concentration (5mg/ml).  The incremental cleared volume was plotted 
against time and the slope of the regression line through the data used to calculate a 
permeability-surface area (PS) value.  PS for the endothelial monolayer (PSe) was calculated 
21
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
from 1/PSe = 1/PSt-1/PSb, where PSt is the regression slope across a test insert and PSb the 
regression slope across a blank (cell free) insert (Dehouck et al, 1992).  PSe values were divided 
by the surface area of the insert (1.13cm2) to derive the endothelial permeability coefficient, Pe 
(cm/min).
Animals.
All animal procedures were approved by the Dalhousie University Committee on Laboratory 
Animals, and comply with guidelines from the Canadian Council on Animal Care.  Male Wistar 
rats aged 30-35 days were purchased from Charles River (Saint-Constant, QB).  Rats were 
housed for a minimum of 5 days to acclimatize them prior to surgery, and were allowed free 
access to pelleted food and water and kept on a 12 hour light/dark cycle.
Surgery.
Inhalational anesthesia was administered using isoflurane (4% induction, 2.5% maintenance) in 
100% oxygen, and depth of anesthesia assessed by foot pinch reflex.  Temperature was 
maintained at 37oC with a heating pad and feedback system attached to a rectal probe (Fine 
Science Tools, Vancouver, BC).  A midline skin incision was made to expose the left jugular 
vein.  Retrograde cannulation was carried out using polyethylene tubing (I.D 0.58mm, O.D. 
0.97mm, Fisher Scientific).  The skin was sutured, and the animal placed prone, and its head 
secured in a stereotactic frame (David Kopf Instruments, Tujunga, CA).  An incision was made 
through the scalp and the skull exposed by skin retraction.  Two burr holes were positioned along 
the coronal suture, 3.5mm on either side of the midline, using a dental drill (Fine Science Tools). 
Injections (4µl ) were then made through a 26 gauge metal needle inserted to a depth of 5mm 
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bilaterally.  To obtain an internal control for each rat, neutrophils (2.5 X 105) were injected into 
the left striatum and a vehicle control (0.9% saline) or positive control (10-3mol/l arachidonic 
acid) were injected into the right striatum.  The needle rested for 1min before injecting at the rate 
of 0.5µl/min with a microinjection unit (David Kopf Instruments).  The needle was left in place 
for 10min before removal to avoid back flux.  Following the stereotactic injections, an interval of 
15min elapsed during which those animals in which we intended to activate neutrophils received 
an intravenous injection of Leukotriene B4 as detailed in the Results, while remaining groups 
were not treated further.  After 15min, the animal was infused through the jugular vein with 
horseradish peroxidase (HRP type IV, 0.35 mg/g dissolved in 200 µl 0.9% saline), which 
circulated for 15min.  Blood samples (100 µl) were taken from the jugular vein at 5, 10 and 
15min after this infusion.  At the end of the infusion period (15min), the rats were given a lethal 
dose (65mg/kg IV) of sodium pentobarbitone (CEVA Sante Animale, La Ballastiere, QC) and 
then perfused through the heart with 50ml saline containing sodium heparin (100U/ml, 4oC) 
followed by 100ml 4% paraformaldehyde (PFA) in phosphate buffered saline (PBS, 50ml/3min 
with a Simon peristaltic pump, Stoeltingco, IL).  A clamp was placed on the descending aorta to 
direct the perfusate towards the head, and the effluent drained through an incision in the right 
atrium.  The brain was then removed from the skull by careful dissection and post fixed for 72h 
in 4% PFA.  It was subsequently immersed in 30% sucrose for 48h to cryoprotect the tissue 
during sectioning on the freezing microtome.
Histology.
Brains were sliced in the coronal plane on a freezing microtome (Microm, Leica, USA) in 
alternating 30µm and 120µm sections and stored in 24 well plates in Millonig buffer solution 
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(containing 0.1mol/l NaH2PO4, 7.85 X 10-2mol/l NaOH in distilled water, pH 7.2, 4oC) prior to 
tissue processing.  The 30µm sections were mounted on silinated glass slides (Fisher Scientific) 
and stained with Mallory’s hematoxylin and eosin (H&E).  The H&E sections were used to 
determine the size of the post-injection hematoma from the presence of red blood cells in the 
needle tract, and to locate the injected neutrophils.  Slides were examined by light microscopy 
with a Nikon Eclipse E600 microscope.  The volume of the hematoma was measured using 
image analysis software (NIH Image J).  Foci of hemorrhage were outlined in the H&E sections 
to determine the surface area in mm2.  This was multiplied by the thickness of the section (30μm 
or 0.03mm) to obtain a volume in μl (where 1μl=1mm3).  The volume was estimated in the 
intervening 120μm sections by taking an average of the areas in the H&E sections immediately 
anterior or posterior to the thicker section and multiplying this by the thickness.  All of the 
sections in each animal were analyzed to obtain a cumulative hematoma volume per rat.  The 
thicker 120µm sections were used to construct permeability-surface area (PS) maps.
Generation of in vivo permeability maps.
The method follows that published by Gauden et al (2007).  The 120µm sections were mounted 
onto silinated slides and reacted with diaminobenzidine (DAB, 8mg/ml) and hydrogen peroxide 
(H2O2,0.006%), that combine with HRP to generate a brown reaction product.  The tissue was 
transilluminated during the reaction through a light box containing a uniform flat field light 
source (3 piece LED, 3M), and sequential images captured every 5s for 200s through a 
stereomicroscope (Leica S6D, Leica Microsystems, Richmond Hill, ON) connected to a camera 
(Hamamatsu C4742-80-12AG, Quorum Technologies, Guelph, ON) with a firewire link to a 
computer (Dell Canada, North York, ON), under the control of customized image processing 
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software (Image Hopper, Samsara Research, Dorking, UK).  To generate images in which pixel 
values increased over time, images of absorption (A) were generated, defined as A=log(Io/It) 
where Io is intensity in the first image and It intensity in subsequent images at a given time, t. 
The initial image was divided by all subsequent images to create a stack of absorption images. 
The absorption series were then processed further to obtain a regression image through the initial 
images (0-35s).  This regression image gives pixel values proportional to the initial rate of 
development of reaction product.  Tissue and plasma calibrations were carried out to demonstrate 
that this initial rate is proportional to HRP concentration.  Brains were obtained from rats 
perfused transcardially with heparinized saline and sectioned into cubes (1cm3).  These were 
incubated in horse serum containing streptomycin (10 µg/ml) and penicillin (20 U/ml) with 
different HRP concentrations for 30h at 37ºC in a static water bath (Electrothermal, England). 
These treatments had been shown to saturate the tissue to a depth of 500μm (Stewart et al., 
1992).  Cubes were then fixed in 4% PFA (72h), cryoprotected in 30% sucrose (48h) and 
sections taken within 500μm of the surface.  The initial rate showed a linear relationship with 
tissue concentration (fig 1, supplementary information).  Plasma calibrations were carried out by 
dissolving known concentrations of HRP in rat plasma taken from an untreated rat.  20µl of 
plasma was mixed with a 4ml mixture of DAB (4mg/ml) and H2O2 (0.006%) and immediately 
transferred to a Petri dish (3.5cm diameter) and placed on the light box to capture images.  The 
initial rate increased in a linear manner with plasma HRP concentration (fig 2, supplementary 
information).
To convert a tissue concentration image into a map of permeability-surface area (PS) product, 
the image was divided by the time-integral product of plasma concentration, derived from the 
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HRP concentration in the blood samples taken at 5, 10 and 15min.  This is based on a modified 
form of the Renkin-Crone equation where PS=Qr/∫(Cpl)dt, where Qr is the amount of HRP in the 
tissue and ∫(Cpl)dt is the time integral concentration of HRP in the plasma (Rapoport, 1978).  The 
three values of plasma concentration were converted to a time integral value using statistical 
software (GraphPad Prism).  The tissue concentration image was then divided by this value to 
obtain a PS map.  The values generated by endogenous peroxidase were estimated using brain 
sections from sham operated rats, and subtracted from the sections.  Over 15min, the HRP that 
enters the brain is expected to distribute in the interstitial space, with minimal uptake by 
surrounding cells.  Therefore the image was further multiplied by a volume term that estimates 
the interstitial volume per gram of tissue (0.2cm3/g, (Go, 1997)).  Because the PS image 
contained many discrete regions, PS was calculated in individual regions of interest (ROI) 
outlined with a hand tool on Image Hopper.  By assuming a tissue thickness of 120μm, and using 
the size of each pixel (19.87μm, obtained from images of metric divisions on a ruler), the volume 
in each ROI was calculated.  The average PS in each ROI was multiplied by this volume to 
obtain a final PS value in ml/s/g.  To ensure that the increase in signal was not due to 
endogenous peroxidase in the vicinity of the injection sites (in neutrophils or red blood cells), a 
subset of animals in each treatment group was processed without infusing HRP.  Images from 
these brains did not show any discernable increase in signal above background under the 
conditions employed, ensuring that the signal observed was due to extravasated HRP and not 
cellular peroxidase.  Other than background staining, signal was also not increased in the brains 
of sham operated animals infused with HRP.  This indicated that signal was not increased from 
retained intravascular HRP due to incomplete flushing of the circulation (data not shown).
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Statistics.
Data from each treatment group is expressed as mean ± standard error of the mean (sem). 
Statistical comparisons between treatment groups were made using statistical software 
(GraphPad Prism).  Multiple groups were compared by one way analysis of variance followed by 
the Tukey test.  Histograms were compared using the X2 test.  P<0.05 was taken as significant.
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Figure legends.
Figure 1.  Permeability responses in the human brain endothelial cell line hCMEC/D3.  Cells 
were pre-treated for 24h with dibutyryl cyclic AMP (dbcAMP, 2.5 X 10-4mol/l) and rolipram 
(1.75 X 10-5mol/l) or treated acutely with arachidonic acid (AA, 0.5 X 10-3mol/l).  The resultant 
permeability is shown as mean ± sem (standard error of the mean), n values indicated. 
Significance is compared to untreated cells (baseline), *P<0.05, **P<0.01.  
Figure 2.  In vitro effects of neutrophil activation.  A.  Neutrophil activation assay.  Change in 
fluorescence over 135min in neutrophils (PMN) loaded with the reactive oxygen species (ROS) 
sensitive fluorescent dye carboxy-2’,7’-dichlorodihydrofluorescein diacetate.  PMN were treated 
with tumor necrosis factor (100U/ml, +TNF), leukotriene B4 (10-7mol/l, +LtB4), alone or 
combined (+TNF+LtB4), phorbyl 12-myristate, 13-acetate (4 X 10-8mol/l, +PMA) alone or 
combined with diphenylene iodinium chloride (DPI, 8 X 10-6 mol/l, +PMA+DPI).  Vehicle 
(phosphate buffered saline, PBS) and DPI were also tested alone.  B.  Permeability changes in 
hCMEC/D3.  Permeability is normalized to baseline permeability in untreated monolayers 
(expressed as % of baseline).  Neutrophils were either applied without treatment (untreated), 
exposed to a gradient of LtB4 (10-7mol/l, LtB4 below), activated with TNF (100U/ml) and LtB4 
(10-7mol/l, activated) or activated in the presence of ROS scavengers (superoxide dismutase 10U/
ml and catalase 1000U/ml, S+C).  As a control, LtB4 (10-7mol/l, LtB4 alone) was applied without 
neutrophils.  Data is expressed as mean ± sem.  Significance is compared to baseline or to 
conditions linked by cross bars (ns=not significant, *P<0.05, **P<0.01, ***P<0.001).
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Figure 3.  Permeability maps around striatal injections of (A) activated neutrophils and (B) 
arachidonic acid (10-3mol/l) into an acute hematoma.  Upper and lower panels show H&E stained 
sections (30μm) taken anterior (upper) and posterior (lower) to the thicker section (120μm) used 
to generate a permeability map (middle panels).  Brain hemisections (left) are shown with a 
highlighted region (box) magnified at right.  The permeability map is pseudocolored to indicate 
graded values of permeability-surface area (PS) product for horseradish peroxidase.  Scale 
bar=200μm.
Figure 4.  PS (permeability-surface area) values in the acute hematoma around neutrophils 
(untreated or activated), vehicle (saline) alone or arachidonic acid (103mol/l).  Data is mean ± 
sem, each data point is compiled for a separate rat (n as indicated).  Significance is compared to 
vehicle or between treatments linked by cross bars (ns=not significant, ***P<0.001).
Figure 5.  Histograms for PS values in individual regions of interest in the permeability maps 
from all of the rats, related to neutrophils (untreated or activated), vehicle (saline) alone or 
arachidonic acid (10-3mol/l).  The number of regions analyzed is shown (n) for each group.  X2 
analysis was used to assess significance relative to activated neutrophils (when P is shown this 
indicates a significant difference, ns=not significant).  
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